Douglas Fambrough, President and CEO at Dicerna Pharmaceuticals Inc (DRNA), bought 10,000 shares at $18.06 ($181K) on 2020-09-01, disclosed to the SEC on 2020-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DRNA | BUY | 2016-11-16 | $123K | — | Filing → |
| DRNA | BUY | 2014-02-20 | $75K | — | Filing → |